Natixis’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
SCM
DM
Natixis's INSP Position: Q2 2026 in Review
Natixis increased its Inspire Medical Systems (INSP) stake by 3.3% in Q2 2026, buying an estimated $3.18K and bringing the position to 2,100 shares worth $93.7K. The position accounts for ﹤0.01% of the portfolio, ranked #997.
Natixis first reported a position in INSP in Q3 2020 and has held it in 16 quarters since. The position peaked at $4.17M in Q4 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- Natixis held 2,100 shares of Inspire Medical Systems worth $93.7K as of Q2 2026.
- Natixis bought 67 Inspire Medical Systems shares in Q2 2026, an estimated $3.18K.
- Inspire Medical Systems made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #997 holding.
- Natixis first reported a position in Inspire Medical Systems in Q3 2020 and has held it in 16 quarters since.
- Natixis's Inspire Medical Systems position peaked at $4.17M in Q4 2022.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.